"Palivizumab" Pronounce,Meaning And Examples

"Palivizumab" Meaning

Palivizumab is a recombinant humanized monoclonal antibody used to prevent respiratory syncytial virus (RSV) infection in high-risk patients, typically premature infants and young children. It is administered intravenously every 28-30 days and is often used in cases of bronchopulmonary dysplasia (BPD), immunodeficiency disorders, or premature birth.

"Palivizumab" Examples

Palivizumab Usage Examples

Example 1: Medical Context

Palivizumab is a monoclonal antibody used to prevent respiratory syncytial virus (RSV) infection in high-risk infants.

Example 2: Research Citation

A recent study published in the Journal of Pediatrics investigated the efficacy of palivizumab in reducing hospital admissions due to RSV bronchiolitis.

Example 3: News Article

Palivizumab is the latest addition to the arsenal of treatments for RSV, and its potential to revolutionize the way we approach pediatric respiratory health is vast.

Example 4: Medical Textbook

Palivizumab is administered intramuscularly every 30 days during the RSV season to high-risk patients, including those with congenital heart disease or chronic lung disease.

Example 5: Academic Paper

Palivizumab has been shown to significantly reduce the incidence of severe RSV illness in premature infants, making it a crucial component of preventive care for this patient population.

(Note: Palivizumab is a brand name for the medication Synagis, used to prevent RSV infection.)